Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function

Journal of Cellular Biochemistry

Volumn 113, Issue 5, 2012, Pages 1478-1487

  Jung, Seok Yun ^a,b   Choi, Jin Hwa ^a   Kwon, Sang Mo ^b   Masuda, Haruchika ^c   Asahara, Takayuki ^c   Lee, You Mie ^a,d  

^a Kyungpook National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c TOKAI UNIVERSITY   (Japan)

^d Kyungpook National University   (South Korea)

Author keywords

DECURSIN; ENDOTHELIAL PROGENITOR CELL; SDF 1 ; TUMOR MICROVESSELS

Indexed keywords

ANGELICA GIGAS EXTRACT; ANGIOGENESIS INHIBITOR; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CD34 ANTIGEN; DECURSIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GREEN FLUORESCENT PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INHIBITION KINETICS; LEWIS CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINDLE CELL; TREATMENT DURATION; TUMOR GROWTH; UMBILICAL CORD BLOOD;

ANGIOGENESIS INHIBITORS; ANIMALS; BASE SEQUENCE; BENZOPYRANS; BUTYRIC ACIDS; CARCINOMA, LEWIS LUNG; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CYTOKINES; DISEASE PROGRESSION; DNA PRIMERS; ENDOTHELIAL CELLS; FETAL BLOOD; GENE EXPRESSION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION; STEM CELLS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANGELICA GIGAS; MUS;

EID: 84859055981     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24085     Document Type: Article

References (37)

1. Ahn KS, Sim WS, Kim IH,. 1996. Decursin: A cytotoxic agent and protein kinase C activator from the root of Angelica gigas. Planta Med 62: 7-9.
2. Aicher A, Heeschen C, Mildner-Rihm C, et al. 2003. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9: 1370-1376. (Pubitemid 37466185)
3. Asahara T, Masuda H, Takahashi T, et al. 1999. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228. (Pubitemid 29377293)
4. Asai J, Takenaka H, Kusano KF, et al. 2006. Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodeling. Circulation 113: 2413-2424. (Pubitemid 43948049)
5. Bertolini F, Paul S, Mancuso P, et al. 2003. Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. Cancer Res 63: 4342-4346. (Pubitemid 36951001)
6. Ceradini DJ, Gurtner GC,. 2005. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 15: 57-63. (Pubitemid 40693388)
7. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. 2004. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10: 858-864. (Pubitemid 39070860)
8. Chakroborty D, Chowdhury UR, Sarkar C, et al. 2008. Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization. J Clin Invest 118: 1380-1389. (Pubitemid 351500431)
9. Dome B, Timar J, Dobos J, et al. 2006. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 66: 7341-7347. (Pubitemid 44197717)
10. Duda DG, Cohen KS, Kozin SV, et al. 2006. Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood 107: 2774-2776.
11. Ferrara N,. 2002. VEGF and the quest for tumor angiogenesis factors. Nat Rev Cancer 2: 795-803. (Pubitemid 37328914)
12. Fidler IJ, Ellis LM,. 1994. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185-188. (Pubitemid 24324908)
13. Folkman J, Watson K, Ingber D, Hanahan D,. 1989. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58-61. (Pubitemid 19115892)
14. Folkman J,. 1990. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6. (Pubitemid 20020880)
15. Guo Y, Wang S, Hoot DR, Clinton SK,. 2007. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. J Nutr Biochem 18: 408-417. (Pubitemid 46727041)
16. Ho JW, Pang RW, Lau C, et al. 2006. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology 44: 836-843. (Pubitemid 46489546)
17. Jung MH, Lee SH, Ahn EM, Lee YM,. 2009. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway. Carcinogenesis 30: 655-661.
18. Kamei N, Kwon SM, Alev C, Ishikawa M, Yokoyama A, Nakanishi K, Yamada K, Horii M, Nishimura H, Takaki S, Kawamoto A, Ii M, Akimaru H, Tanaka N, Nishikawa S, Ochi M, Asahara T,. 2010. Lnk deletion reinforces the function of bone marrow progenitors in promoting neovascularization and astrogliosis following spinal cord injury. Stem Cells 28: 365-375.
19. Kim HH, Sik Bang S, Seok Choi J, Han H, Kim IH,. 2005. Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structure-activity relationship in human K562 erythroleukemia and U937 myeloleukemia cells. Cancer Lett 223: 191-201. (Pubitemid 40719617)
20. Kim JH, Kim JH, Lee YM, et al. 2009a. Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation. Mol Vis 15: 1868-1875.
21. Kim JH, Kim JH, Lee YM, et al. 2009b. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation. J Cereb Blood Flow Metab 29: 1559-1567.
22. Konoshima M, Chi H, Hata K,. 1968. Coumarins from the root of Angelica gigas Nakai. Chem Pharm Bull (Tokyo) 6: 1139-1140.
23. Kwon SM, Eguchi M, Wada M, et al. 2008. Specific Jagged-1 signal from bone marrow microenvironment is required for endothelial progenitor cell development for neovascularization. Circulation 118: 157-165.
24. Kwon SM, Lee YK, Yokoyama A, Jung SY, Masuda H, Kawamoto A, Lee YM, Asahara T,. 2011. Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization. J Mol Cell Cardiol 51: 308-317.
25. Kwon SM, Suzuki T, Kawamoto A, Ii M, Eguchi M, Akimaru H, Wada M, Matsumoto T, Masuda H, Nakagawa Y, Nishimura H, Kawai K, Takaki S, Asahara T,. 2009. Pivotal role of lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration. Circ Res 104: 969-977.
26. Lee S, Shin DS, Kim JS, Oh KB, Kang SS,. 2003. Antibacterial coumarins from Angelica gigas roots. Arch Pharm Res 26: 449-452. (Pubitemid 43073812)
27. Li X, Han Y, Pang W, et al. 2008. AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28: 1789-1795.
28. Losordo DW, Vale PR, Symes JF, et al. 1998. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98: 2800-2804. (Pubitemid 29003959)
29. Lyden D, Hattori K, Dias S, et al. 2001. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7: 1194-1201. (Pubitemid 33063774)
30. Masuda H, Alev C, Akimaru H, Ito R, Shizuno T, Kobori M, Horii M, Ishihara T, Isobe K, Isozaki M, Itoh J, Itoh Y, Okada Y, McIntyre BA, Kato S, Asahara T,. 2011. Methodological development of a clonogenic assay to determine endothelial progenitor cell potential. Circ Res 109: 20-37.
31. Murohara T, Asahara T, Silver M, et al. 1998. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578. (Pubitemid 28270451)
32. Nolan DJ, Ciarrocchi A, Mellick AS, et al. 2007. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 21: 1546-1558. (Pubitemid 46955726)
33. Sarker SD, Nahar L,. 2004. Natural medicine: The genus Angelica. Curr Med Chem 11: 1479-1500. (Pubitemid 38735791)
34. Son SH, Kim MJ, Chung WY, et al. 2009. Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase. Cancer Lett 280: 86-92.
35. Spring H, Schuler T, Arnold B, Hammerling GJ, Ganss R,. 2005. Chemokines direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci USA 102: 18111-18116. (Pubitemid 41798510)
36. Yancopoulos GD, Davis S, Gale NW, et al. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248.
37. Zheng H, Fu G, Dai T, Huang H,. 2007. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 50: 274-280. (Pubitemid 47428975)